Cargando…
Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study
OBJECTIVE: To develop a method for estimating the future numbers of prostate cancer survivors requiring different levels of care. DESIGN, SETTING AND PARTICIPANTS: Analysis of population-based cancer registry data for prostate cancer cases (aged 18–84 years) diagnosed in 1996–2007, and a linked data...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298320/ https://www.ncbi.nlm.nih.gov/pubmed/28178275 http://dx.doi.org/10.1371/journal.pone.0171013 |
_version_ | 1782505856280035328 |
---|---|
author | Yu, Xue Qin Luo, Qingwei Smith, David P. Clements, Mark S. Patel, Manish I. O’Connell, Dianne L. |
author_facet | Yu, Xue Qin Luo, Qingwei Smith, David P. Clements, Mark S. Patel, Manish I. O’Connell, Dianne L. |
author_sort | Yu, Xue Qin |
collection | PubMed |
description | OBJECTIVE: To develop a method for estimating the future numbers of prostate cancer survivors requiring different levels of care. DESIGN, SETTING AND PARTICIPANTS: Analysis of population-based cancer registry data for prostate cancer cases (aged 18–84 years) diagnosed in 1996–2007, and a linked dataset with hospital admission data for men with prostate cancer diagnosed during 2005–2007 in New South Wales (NSW), Australia. METHODS: Cancer registry data (1996–2007) were used to project complete prostate cancer prevalence in NSW, Australia for 2008–2017, and treatment information from hospital records (2005–2007) was used to estimate the inpatient care needs during the first year after diagnosis. The projected complete prevalence was divided into care needs-based groups. We first divided the cohort into two groups based on patient’s age (<75 and 75–84 years). The younger cohort was further divided into initial care and monitoring phases. Cause of death data were used as a proxy for patients requiring last year of life prostate cancer care. Finally, episode data were used to estimate the future number of cases with metastatic progression. RESULTS: Of the estimated total of 60,910 men with a previous diagnosis of prostate cancer in 2017, the largest groups will be older patients (52.0%) and younger men who require monitoring (42.5%). If current treatment patterns continue, in the first year post-diagnosis 41% (1380) of patients (<75 years) will have a radical prostatectomy, and 52.6% (1752) will be likely to have either active surveillance, external beam radiotherapy or androgen deprivation therapy. About 3% will require care for subsequent metastases, and 1288 men with prostate cancer are likely to die from the disease in 2017. CONCLUSIONS: This method extends the application of routinely collected population-based data, and can contribute much to the knowledge of the number of men with prostate cancer and their health care requirements. This could be of significant use in planning future cancer care services and facilities in Australia. |
format | Online Article Text |
id | pubmed-5298320 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-52983202017-02-17 Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study Yu, Xue Qin Luo, Qingwei Smith, David P. Clements, Mark S. Patel, Manish I. O’Connell, Dianne L. PLoS One Research Article OBJECTIVE: To develop a method for estimating the future numbers of prostate cancer survivors requiring different levels of care. DESIGN, SETTING AND PARTICIPANTS: Analysis of population-based cancer registry data for prostate cancer cases (aged 18–84 years) diagnosed in 1996–2007, and a linked dataset with hospital admission data for men with prostate cancer diagnosed during 2005–2007 in New South Wales (NSW), Australia. METHODS: Cancer registry data (1996–2007) were used to project complete prostate cancer prevalence in NSW, Australia for 2008–2017, and treatment information from hospital records (2005–2007) was used to estimate the inpatient care needs during the first year after diagnosis. The projected complete prevalence was divided into care needs-based groups. We first divided the cohort into two groups based on patient’s age (<75 and 75–84 years). The younger cohort was further divided into initial care and monitoring phases. Cause of death data were used as a proxy for patients requiring last year of life prostate cancer care. Finally, episode data were used to estimate the future number of cases with metastatic progression. RESULTS: Of the estimated total of 60,910 men with a previous diagnosis of prostate cancer in 2017, the largest groups will be older patients (52.0%) and younger men who require monitoring (42.5%). If current treatment patterns continue, in the first year post-diagnosis 41% (1380) of patients (<75 years) will have a radical prostatectomy, and 52.6% (1752) will be likely to have either active surveillance, external beam radiotherapy or androgen deprivation therapy. About 3% will require care for subsequent metastases, and 1288 men with prostate cancer are likely to die from the disease in 2017. CONCLUSIONS: This method extends the application of routinely collected population-based data, and can contribute much to the knowledge of the number of men with prostate cancer and their health care requirements. This could be of significant use in planning future cancer care services and facilities in Australia. Public Library of Science 2017-02-08 /pmc/articles/PMC5298320/ /pubmed/28178275 http://dx.doi.org/10.1371/journal.pone.0171013 Text en © 2017 Yu et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Yu, Xue Qin Luo, Qingwei Smith, David P. Clements, Mark S. Patel, Manish I. O’Connell, Dianne L. Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study |
title | Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study |
title_full | Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study |
title_fullStr | Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study |
title_full_unstemmed | Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study |
title_short | Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study |
title_sort | phase of care prevalence for prostate cancer in new south wales, australia: a population-based modelling study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298320/ https://www.ncbi.nlm.nih.gov/pubmed/28178275 http://dx.doi.org/10.1371/journal.pone.0171013 |
work_keys_str_mv | AT yuxueqin phaseofcareprevalenceforprostatecancerinnewsouthwalesaustraliaapopulationbasedmodellingstudy AT luoqingwei phaseofcareprevalenceforprostatecancerinnewsouthwalesaustraliaapopulationbasedmodellingstudy AT smithdavidp phaseofcareprevalenceforprostatecancerinnewsouthwalesaustraliaapopulationbasedmodellingstudy AT clementsmarks phaseofcareprevalenceforprostatecancerinnewsouthwalesaustraliaapopulationbasedmodellingstudy AT patelmanishi phaseofcareprevalenceforprostatecancerinnewsouthwalesaustraliaapopulationbasedmodellingstudy AT oconnelldiannel phaseofcareprevalenceforprostatecancerinnewsouthwalesaustraliaapopulationbasedmodellingstudy |